Investigational New Drugs · 2019 · 43 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer ImmunotherapyColorectal CancerGastrointestinal Cancer PharmacotherapyGastrointestinal PharmacologyOncology PharmacologyPharmacodynamics Of Anticancer AgentsColorectal Cancer ChemopreventionColorectal Carcinogenesis PathophysiologyIrinotecan-based TherapyParp InhibitionParp Inhibitor ResistanceParp Inhibitor SensitivityRucaparib Therapy
36
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Systematic variation in gene expression patterns in human cancer cell lines
Douglas T. Ross, Uwe Scherf, Michael B. Eisen et al. · Nature Genetics · 2000 · 2.1K citations
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Yardena Samuels, Luis A. Díaz, Oleg Schmidt‐Kittler et al. · Cancer Cell · 2005 · 919 citations · Full text
Medicine, Cancer Biology, Oncology +16
Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki- <i>ras</i>
Senji Shirasawa, Masanori Furuse, Nobuhiko Yokoyama et al. · Science · 1993 · 627 citations